PerspectiveInflammation

Leukotriene Inflammatory Mediators Meet Their Match

Science Translational Medicine  19 Jan 2011:
Vol. 3, Issue 66, pp. 66ps3
DOI: 10.1126/scitranslmed.3002040

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Leukotrienes are arachidonic acid–derived lipid mediators of inflammation. The initial catalytic step in the formation of leukotrienes is catalyzed by 5-lipoxygenase (5-LOX) in conjunction with its activating partner protein FLAP. The long-awaited crystal structure of 5-LOX—reported in a recent issue of Science—should lead to novel, purpose-designed inhibitors for the treatment of asthma and for probing leukotriene involvement in cardiovascular disease and cancer.

Footnotes

  • Citation: C. D. Funk, Leukotriene Inflammatory Mediators Meet Their Match. Sci. Transl. Med. 3, 66ps3 (2011).

View Full Text